C4X Discovery Holdings ผลตอบแทนจากการลงทุน 2024

C4X Discovery Holdings ทำอะไร?

C4X Discovery Holdings PLC is a biopharmaceutical company specializing in the discovery of drugs for various therapeutic areas. It was founded in 2008 to explore a new generation of drugs tailored to the needs of patients and healthcare providers. The company focuses on identifying new drugs through its proprietary technology platform CONFORMER® and forming partnerships with pharmaceutical companies to develop and market these medications. It is divided into different business segments specializing in neurology, inflammation and autoimmune diseases, oncology, and antiviral drugs. C4X Discovery has several products in different stages of development, with promising candidates for idiopathic pulmonary fibrosis, cancer therapeutics, and chronic pain receptor agonists. The company follows an open innovation strategy, collaborating closely with academic researchers and corporate partners to find new approaches in drug development. It has partnerships with various pharmaceutical and biotech companies, as well as academic institutions. C4X Discovery also has its own platform called Taxonomy3®, which enables accurate prediction of target proteins and accelerates the drug discovery process. Overall, C4X Discovery is an innovative company focused on identifying and developing drugs tailored to unmet needs of patients and healthcare providers. Through its open innovation approach and collaborations, it is well positioned to contribute to future advancements in drug discovery and play a crucial role in medication development. C4X Discovery Holdings เป็นหนึ่งในบริษัทที่ได้รับความนิยมมากที่สุดบน Eulerpool.com.